Oral anticoagulant therapy: Should doctors change the way they give patients explanations?

Thrombosis and Haemostasis

Volumn 90, Issue 1, 2003, Pages 159-160

  Barcellona, Doris ^b   Fenu, Lara ^b   Marongiu, Francesco ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; COUMARIN ANTICOAGULANT; LONG ACTING DRUG; SHORT ACTING DRUG; UNCLASSIFIED DRUG; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; CLINICAL TRIAL; DIET; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; LETTER; MEDICAL PRACTICE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PREGNANCY; PRIORITY JOURNAL; SEASONAL VARIATION; SOCIOECONOMICS; TERATOGENICITY; THROMBOSIS;

EID: 0038637494     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613615     Document Type: Letter

References (5)

1. Laporte S, Quenet S, Buchmuller-Cordier A, et al. Compliance and stability of INR of two oral anticoagulants with different half-lives: A randomised trial. Thromb Haemost 2003, 89: 458-67.
2. Pattaccini C, Tagliaferri A, Manotti C. Awarness of teratogenic effect of oral anticoagulants in fertile women. Thromb Haemost 2002; 88: 172.
3. Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica 2002; 87: 1081-86.
4. Barcellona D, Contu P, Sorano GG, et al. The management of oral anticoagulant therapy: The patient's point of view. Thromb Haemost 2000; 83: 49-53.
5. Barcellona D, Vannini ML, Fenu L, et al. Warfarin or acenocoumarol: Which is better in the management of oral anticoagulants? Thromb Haemost 1998; 80: 899-902.